Last reviewed · How we verify
rabeprazole and pantoprazole — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
rabeprazole and pantoprazole (rabeprazole and pantoprazole) — PriCara, Unit of Ortho-McNeil, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| rabeprazole and pantoprazole TARGET | rabeprazole and pantoprazole | PriCara, Unit of Ortho-McNeil, Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- rabeprazole and pantoprazole CI watch — RSS
- rabeprazole and pantoprazole CI watch — Atom
- rabeprazole and pantoprazole CI watch — JSON
- rabeprazole and pantoprazole alone — RSS
Cite this brief
Drug Landscape (2026). rabeprazole and pantoprazole — Competitive Intelligence Brief. https://druglandscape.com/ci/rabeprazole-and-pantoprazole. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab